Hong Kong · Delayed Price · Currency is HKD CSPC Pharmaceutical Group Statistics
Total Valuation
HKG:1093 has a market cap or net worth of HKD 99.35 billion. The enterprise value is 89.85 billion.
| Market Cap | 99.35B |
| Enterprise Value | 89.85B |
Important Dates
The next confirmed earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Jun 24, 2026 |
Share Statistics
HKG:1093 has 11.43 billion shares outstanding. The number of shares has decreased by -1.93% in one year.
| Current Share Class | 11.43B |
| Shares Outstanding | 11.43B |
| Shares Change (YoY) | -1.93% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 26.49% |
| Owned by Institutions (%) | 34.27% |
| Float | 7.65B |
Valuation Ratios
The trailing PE ratio is 26.73 and the forward PE ratio is 8.74. HKG:1093's PEG ratio is 1.29.
| PE Ratio | 26.73 |
| Forward PE | 8.74 |
| PS Ratio | 3.43 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.89 |
| P/FCF Ratio | 22.05 |
| P/OCF Ratio | 14.64 |
| PEG Ratio | 1.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.88, with an EV/FCF ratio of 19.94.
| EV / Earnings | 24.22 |
| EV / Sales | 3.11 |
| EV / EBITDA | 16.88 |
| EV / EBIT | 23.62 |
| EV / FCF | 19.94 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.16 |
| Interest Coverage | 79.79 |
Financial Efficiency
Return on equity (ROE) is 9.57% and return on invested capital (ROIC) is 10.88%.
| Return on Equity (ROE) | 9.57% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.88% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.37% |
| Revenue Per Employee | 1.47M |
| Profits Per Employee | 188,325 |
| Employee Count | 19,700 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HKG:1093 has paid 993.12 million in taxes.
| Income Tax | 993.12M |
| Effective Tax Rate | 21.07% |
Stock Price Statistics
The stock price has decreased by -18.94% in the last 52 weeks. The beta is 0.75, so HKG:1093's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -18.94% |
| 50-Day Moving Average | 7.89 |
| 200-Day Moving Average | 8.45 |
| Relative Strength Index (RSI) | 57.83 |
| Average Volume (20 Days) | 70,951,927 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1093 had revenue of HKD 28.94 billion and earned 3.71 billion in profits. Earnings per share was 0.33.
| Revenue | 28.94B |
| Gross Profit | 18.89B |
| Operating Income | 3.89B |
| Pretax Income | 4.71B |
| Net Income | 3.71B |
| EBITDA | 5.21B |
| EBIT | 3.89B |
| Earnings Per Share (EPS) | 0.33 |
Balance Sheet
The company has 11.79 billion in cash and 728.73 million in debt, with a net cash position of 11.06 billion or 0.97 per share.
| Cash & Cash Equivalents | 11.79B |
| Total Debt | 728.73M |
| Net Cash | 11.06B |
| Net Cash Per Share | 0.97 |
| Equity (Book Value) | 39.27B |
| Book Value Per Share | 3.30 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 6.79 billion and capital expenditures -2.28 billion, giving a free cash flow of 4.51 billion.
| Operating Cash Flow | 6.79B |
| Capital Expenditures | -2.28B |
| Depreciation & Amortization | 1.36B |
| Net Borrowing | -169.77M |
| Free Cash Flow | 4.51B |
| FCF Per Share | 0.39 |
Margins
Gross margin is 65.29%, with operating and profit margins of 13.44% and 12.82%.
| Gross Margin | 65.29% |
| Operating Margin | 13.44% |
| Pretax Margin | 16.29% |
| Profit Margin | 12.82% |
| EBITDA Margin | 18.02% |
| EBIT Margin | 13.44% |
| FCF Margin | 14.89% |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 3.34%.
| Dividend Per Share | 0.29 |
| Dividend Yield | 3.34% |
| Dividend Growth (YoY) | 11.54% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.93% |
| Shareholder Yield | 5.21% |
| Earnings Yield | 3.73% |
| FCF Yield | 4.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:1093 is 11.72, which is 34.87% higher than the current price. The consensus rating is "Buy".
| Price Target | 11.72 |
| Price Target Difference | 34.87% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 8.22% |
| EPS Growth Forecast (3Y) | 30.68% |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Oct 15, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |